Searched for
PHARMA AND BIOTECH FIRMS
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Rx Propellant commits $100 million to build India’s largest life sciences campus in HyderabadRx Propellant will invest $100 million in Hyderabad's Genome Valley. A new life sciences campus will be built over six years. This project ...
- Probe into Uzbekistan cough syrup deaths: 3 employees of Noida-based Marion Biotech arrestedThe arrests come after an FIR was lodged late Thursday night against five officials of Marion Biotech, including two of its directors, over...
- Lupin appoints Spiro Gavaris as president of US generics bizSpiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...
- Bharat Biotech studying if Covaxin shot will work on Omicron"Covaxin was developed against the original Wuhan variant," a Bharat Biotech spokesperson told Reuters in a text message, referring to the ...
- Lupin Pharma gets Good Manufacturing Certificate for its biologic plantBiosimilar Etanercept is used to fight a range of severe auto-immune disorders.
- Pharma institutes sign 17 MoUs with corporatesNational pharmaceutical institutes have signed 17 agreements with drug firms, including Dr Reddys, Sun Pharma and Wockhardt.
- A company called ISIS had a massive day on the stock marketAccording to Nasdaq, the stock price of ISIS Pharmaceuticals crossed above its 200-day moving average for the first time since early spring.
- A company called ISIS had a massive day on the stock marketISIS Pharmaceuticals, a $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months.
- Budget 2014: Government needs to invest $5 billion per year for next 5 years in biotech, recommends PwCThe consultancy firm has also asked the government to allocate Rs 500 crore each year from the R&D cess accessible by the Technology Develo...
- Biocon among world's top pharma employers"The Biocon employer brand has been growing stronger with each passing year, and our increased success in attracting talent is a testimony ...
- Mumbai firms beat B'lore peers in biotech zoneCompanies based in Mumbai and other parts of western India dominate the Indian biotech sector, pushing Bangalore down to second place, a su...
- Indian biotech sector rebounds on global recoveryIndia's biotech industry bounced to high growth in fiscal 2009-10 to post revenues of $4 billion, a whopping 52 per cent over the previous ...
- Pfizer keen to buy Wockhardt's biotech businessThe American company has just completed the $68-billion acquisition of biotech major Wyeth, which is a new drug developer.
- Pharmaceutical firm to invest USD 300 mn in MalaysiaMalladi Drugs and Pharmaceutical Ltd will invest up to USD 300 million over the next three to five years to set up its global "one-stop sho...
- Bengal to rope in biotech giantsAfter establishing Kolkata as a top IT/ITeS destination, the West Bengal government intends to replicate that success in the biotech turf.
Load More
